Reneo Pharmaceuticals Inc.
- Address
- 18575 Jamboree Road Suite 275s
Sponsor Overview
Specializations
Hepatic Function
Reneo Pharmaceuticals Inc. is focused on clinical research involving impaired hepatic function, with attention to how investigational therapies are handled in people with normal liver function and varying degrees of hepatic impairment.
- Normal hepatic function
- Mild hepatic impairment
- Moderate hepatic impairment
- Severe hepatic impairment
The sponsor’s research interest centers on pharmacokinetics in liver-compromised populations, supporting evaluation of treatment behavior across clinically relevant levels of liver dysfunction.
Metabolic and Organ-Specific Drug Handling
The clinical program reflects interest in how medicines are processed in the presence of altered hepatic metabolism, with relevance to patients whose organ function may affect exposure and response.
- Drug disposition
- Organ impairment assessment
- Exposure evaluation
This area supports development work aimed at understanding therapeutic use in populations with reduced liver clearance and other impairment-related changes.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Pharmacokinetics of Mavodelpar in Subjects with Varying Degrees of Hepatic Impairment: A Phase 1, Open-Label, Single-Dose Study | Hungary | Not Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 1 site across their trial portfolio.
Therapeutic Focus
- 1.Not possible to specify1 trial220 other sponsors
Partnered Research Centres
1 centre- Address
- Thokoly Utca 15, Felsogod, 2132 God
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Reneo Pharmaceuticals Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.

